Jeffrey Barnes

14PUBLICATIONS
134CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markersChemotherapyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 30, 2026
Zanubrutinib, Obinutuzumab, and Venetoclax in CLL: Long-Term Follow Up, MRD Kinetics, Retreatment, T-Cell Profiling, PKs.

|Oct 31, 2025
A retrospective study of treatment and outcomes in synchronous systemic and central nervous system large B-cell lymphoma.

J Erika Haydu, Robert A Redd, Matthew M Lei

|Jul 15, 2025
Clinical presentation, management, and outcome of TIAN in CNS lymphoma treated with CD19-CAR T-cell therapy.

Leon D Kaulen, Maria Martinez-Lage, Jeremy S Abramson

|Jun 17, 2025
Real-world evidence of duvelisib and romidepsin in relapsed/refractory peripheral and cutaneous T-cell lymphomas.

Josie G Ford, Min Jung Koh, Alexandra W Lenart

|Mar 03, 2025
A low lymphocyte-to-monocyte ratio is independently associated with early relapse (POD24) in high tumour burden follicular lymphoma: A RELEVANCE subanalysis.

Pablo Mozas, Romain Ould Ammar, Loïc Chartier

|Jan 09, 2025
Odronextamab monotherapy in R/R DLBCL after progression with CAR T-cell therapy: primary analysis of the ELM-1 study.

Max S Topp, Matthew Matasar, John N Allan

Pageof 3

Frequent Collaborators

8 joint publications

Jeremy S Abramson

6 joint publications

Patrick Connor Johnson

4 joint publications

Jacob D Soumerai

3 joint publications

Ann S LaCasce